Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05964439 · ClinicalTrials.gov registry record · NA

Augmented Reality Ultrasound Guidance

A NA study of Paracentesis, sponsored by Children's National Research Institute.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT05964439: Recruiting NA study of Paracentesis, sponsored by Children's National Research Institute.

NCT05964439 is a NA study of Paracentesis that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05964439, a NA study of Paracentesis, is actively recruiting participants, sponsored by Children's National Research Institute.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

Many medical procedures are done with the aid of ultrasound imaging, but they remain difficult to learn and perform. This study will use augmented reality technology for making these procedures potentially more intuitive, easier, more precise, and safer.

Conditions Studied

Interventions

  • DEVICE HoloUS app for ultrasound visualization

Study Locations (1)

District of Columbia

  • Children's National Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2022-03-11
Est. Completion 2024-12-31
Phase NA

What NCT05964439 shows while recruiting

NCT05964439 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Paracentesis appearing as the primary indexed condition, and to 1 intervention - of which HoloUS app for ultrasound visualization is the first listed.

NCT05964439 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05964439 about?

NCT05964439 is a clinical study titled "Augmented Reality Ultrasound Guidance". Many medical procedures are done with the aid of ultrasound imaging, but they remain difficult to learn and perform. This study will use augmented reality technology for making these procedures potentially more intuitive, easier, more precise, and safer.

What is the current status of trial NCT05964439?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2022-03-11. Estimated completion is 2024-12-31.

What conditions does trial NCT05964439 study?

This clinical trial studies the following conditions: Paracentesis.

What interventions are being tested in trial NCT05964439?

The interventions under investigation include: HoloUS app for ultrasound visualization (DEVICE).

Who is sponsoring clinical trial NCT05964439?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05964439 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT05964439's enrollment target sits among peer trials

44 1423rd of 2000 higher than 566 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05964439, the US trial registry maintained by the National Library of Medicine. NCT05964439 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.